8-K: DENTSPLY SIRONA Announces CFO Departure, Interim Successor

DENTSPLY SIRONA Inc. announced the departure of its Executive Vice President and Chief Financial Officer, Matthew E. Garth, effective November 5, 2025, with CEO Daniel T. Scavilla assuming interim principal financial officer duties.

Summary

• Matthew E. Garth will no longer serve as the Executive Vice President and Chief Financial Officer of DENTSPLY SIRONA Inc., effective November 5, 2025.
• The company has initiated a search process to identify its next Chief Financial Officer.
• Mr. Garth's departure was not due to any disagreement with the company on matters relating to financial statements, internal controls, operations, or accounting principles and practices.
• Daniel T. Scavilla, the company's President and Chief Executive Officer and a member of the Board of Directors, has been appointed to the additional role of interim principal financial officer for SEC filing purposes, effective November 5, 2025.
• No new compensatory arrangements will be entered into with Mr. Scavilla in connection with his assumption of interim principal financial officer responsibilities.
• An amendment to this Current Report on Form 8-K will be filed after arrangements relating to Mr. Garth's cessation of service have been finalized.

Sentiment

Score: 5

Explanation: The departure of a CFO is a neutral to slightly negative event due to leadership uncertainty, but the explicit statement that it was not due to financial disagreements and the immediate appointment of an interim CFO mitigate significant negative sentiment.

Positives

• The company explicitly stated that Mr. Garth's departure was not due to any disagreement regarding financial statements, internal controls, or accounting practices, which helps mitigate concerns about financial integrity.
• The immediate appointment of CEO Daniel T. Scavilla as interim principal financial officer ensures continuity in financial reporting responsibilities during the transition period.

Negatives

• The departure of a key executive like the CFO creates uncertainty and a potential disruption in financial leadership.
• The company will need to expend resources and time on a search for a new permanent CFO, which can be a lengthy process.

Risks

• Uncertainty regarding the transition period and the search for a new permanent Chief Financial Officer could impact investor confidence.
• Potential for disruption in financial operations or strategic initiatives during the interim period while the CEO manages dual roles.

Future Outlook

The company has initiated a search process to identify its next Chief Financial Officer and plans to file an amendment to this Current Report on Form 8-K after arrangements relating to Mr. Garth's cessation of service have been finalized.

Management Comments

• Mr. Garths departure was not because of any disagreement with the Company on any matter relating to the Companys financial statements, internal controls or operations, including accounting principles and practices.

Industry Context

The departure of a CFO is a significant event for any publicly traded company, particularly in the healthcare or dental equipment sector where financial stability and strategic direction are crucial. While the filing states no disagreement over financial matters, such changes often prompt investor scrutiny regarding leadership stability and future strategic direction. Competitors will likely monitor the transition and the appointment of a permanent CFO.

Management Changes

Stakeholder Impact

• Shareholders: May experience short-term uncertainty due to leadership change, but the clear statement about no financial disagreements could reassure them. The search for a new CFO will be closely watched.
• Employees: Potential for internal shifts and adjustments within the finance department.
• Customers/Suppliers: Unlikely to have direct immediate impact, but long-term strategic direction under new financial leadership could eventually influence relationships.
• Creditors: The continuity provided by an interim CFO and the stated lack of financial disagreements should prevent immediate concerns, but they will monitor the permanent CFO appointment.

Next Steps

• The company will conduct a search process to identify its next Chief Financial Officer.
• The company will file an amendment to this Current Report on Form 8-K after any arrangements relating to Mr. Garth's cessation of service have been finalized.

Key Dates

Recommendation

The departure of a Chief Financial Officer is a significant event that introduces a degree of uncertainty regarding the company's financial leadership and strategic direction. While the filing explicitly states that the departure was not due to disagreements over financial statements or internal controls, which is a positive, the company is now in a transition period. The appointment of the CEO as interim CFO provides continuity but also adds to the CEO's workload. Investors should hold their position and monitor the company's progress in identifying and appointing a permanent CFO, as well as any subsequent strategic or financial updates, before making further investment decisions.

Keywords

DENTSPLY SIRONA, XRAY, CFO, Chief Financial Officer, Executive Change, Management Change, Interim CFO, Corporate Governance, SEC Filing, Dental Industry